AI assistant
Pluri Inc. — Director's Dealing 2014
Sep 16, 2014
6990_rns_2014-09-16_17a5f6d0-1952-4429-ad77-a24c110c3c04.pdf
Director's Dealing
Open in viewerOpens in your device viewer
FORM 4
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
| OMB APPROVAL | |
|---|---|
| OMB Number: | 3235-0287 |
| Expires: | December 31, 2014 |
| Estimated average burden hours | 0.5 |
| per response | |
| 1. Name and Address of Reporting Person* YANAY YAKY 0001402539 | |
| --- | --- |
| (Last) | (First) (Middle) |
| 14 ARGAMAN ST. | |
| (Street) | |
| SHIMSHIT | L3 17906 |
| (City) | (State) (Zip) |
| 2. Issuer Name and Ticker or Trading Symbol PLURISTEM THERAPEUTICS INC [PSTI] | |
| --- | --- |
| 3. Date of Earliest Transaction (Month/Day/Year) 09/16/2014 | |
| 4. If Amendment, Date of Original Filed (Month/Day/Year) | |
| 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) | |
| --- | --- |
| Director | 10% Owner |
| X Officer (give title below) | Other (specify below) |
| COO & President | |
| 6. Individual or Joint/Group Filing (Check Applicable Line) | |
| X Form filed by One Reporting Person | |
| Form filed by More than One Reporting Person | |
| Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | |
| --- | --- |
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) |
| Common Stock | 09/16/2014 |
| Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |
| --- | --- |
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security |
Explanation of Responses:
- The purchase was effected on the Tel Aviv Stock Exchange in New Israeli Shekels (NIS) for per share purchase price of NIS 10.33, which per share purchase price has been reported on this Form 4 in U.S. dollars based on an exchange rate of NIS 3.626 per U.S. dollar.
Remarks:
/s/ Yaky Yanay ** Signature of Reporting Person
09/16/2014 Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
- If the form is filed by more than one reporting person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.